DUBLIN, Apr. 09, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/5crf5h/middle_east_and) has announced the addition of the "Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market [Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electric Neurostimulation] - Forecasts till 2019" report to their offering.
The internal neuromodulation market is estimated to grow the fastest in Saudi Arabia, at a CAGR of 17.9% from 2014 to 2019; while the largest market share is held by the South African internal neuromodulation segment, which is expected to grow at a CAGR of 13.1% during the given forecast period.
The rise in the incidences and prevalence of neurological diseases, rapid growth in aging population, development of advanced neurostimulation technologies, and the increasing awareness among the key factors that are fueling the growth of the internal neuromodulation technologies market in Saudi Arabia, South Africa, and Turkey. However, the lack of skilled professionals and unfavorable reimbursement scenario aresome of the key challenges faced by market players.
The emerging markets such as Saudi Arabia, South Africa, and Turkey have become attractive for companies engaged in the development and marketing of the internal neuromodulation implants. Rising neurological disorders and the governments' initiatives to increase awareness through education campaigns are the key factors propelling the demand of the internal neuromodulation technologies in these emerging market segments.
Medtronic, Inc. (U.S.) held the leading position in the Saudi Arabia, South Africa, and Turkish internal neuromodulation market. Besides Medtronic, St. Jude Medical Inc. (U.S.) and Boston Scientific Inc. (U.S.) are among other key players contributing to the concerned market. Companies such as Aleva Neurotherapeutics SA are operative in Saudi Arabian and South African deep brain stimulation modality, while Cyberonics, Inc. (U.S.) and Dynatronics Corporation (U.S.) are operational in the vagus nerve stimulation modality in these 3 countries.
Scope of the Report
Saudi Arabia, South Africa and Turkey Internal Neuromodulation Market, by Modality:
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagus Nerve Stimulation
- Gastric Neurostimulation
Saudi Arabia, South Africa and Turkey Internal Neuromodulation Market, by Application:
- Spinal Cord Stimulation
- - Chronic Pain
- - Failed back surgery syndrome
- - Ischemic Pain
- - Others
- Deep Brain Stimulation
- Parkinson's Disease
- - Tremor
- - Depression
- - Others (including Chronic Pain, Dystonia, Tourette's Syndrome, and Alzheimer's)
- Sacral Nerve Stimulation
- - Urinary Incontinence
- - Fecal Incontinence
- Vagus Nerve Stimulation
- - Epilepsy
- - Others
- Gastric Neurostimulation
- - Gastroparesis
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Market Overview
5 Internal Neurostimulation/Neuromodulation Market, By Modality
6 Internal Neurostimulation/Neuromodulation Market, By Application
7 Internal Neurostimulation/Neuromodulation Market: Competitive Landscape
8 Internal Neurostimulation/Neuromodulation Market, By Company
9 Appendix
Companies Mentioned
- Aleva Neurotherapeutics SA
- Boston Scientific Corporation
- Cyberonics Inc.
- Dynatronics Corporation
- Medtronic Inc.
- St. Jude Medical Inc.
For more information visit http://www.researchandmarkets.com/research/5crf5h/middle_east_and
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
